Management of Laryngitis
For acute viral laryngitis, focus on symptomatic relief with analgesics, hydration, and voice rest—antibiotics should NOT be prescribed as they provide no objective benefit and contribute to antibiotic resistance. 1
Initial Assessment and Diagnosis
When evaluating laryngitis, determine whether the presentation is acute viral, chronic inflammatory, or bacterial:
- Acute viral laryngitis is most common, caused by parainfluenza, rhinovirus, influenza, and adenovirus, and is self-limited with symptom improvement within 7-10 days regardless of treatment 1, 2
- Laryngoscopy is mandatory if dysphonia persists beyond 3-4 weeks, if there are signs of airway compromise, progressive worsening, or suspicion of alternative diagnoses 1, 2
- Colored mucus does NOT differentiate viral from bacterial infection—this is a critical pitfall to avoid 2
Treatment Algorithm for Acute Viral Laryngitis
First-Line Symptomatic Management
- Analgesics or antipyretics for pain or fever relief 2
- Adequate hydration to reduce vocal fold irritation 2
- Voice rest to minimize vocal fold trauma 2
- Expected resolution within 7-10 days without specific treatment 1
What NOT to Do
- Do NOT prescribe antibiotics routinely—they show no objective benefit in acute viral laryngitis and expose patients to unnecessary side effects (rash, abdominal pain, diarrhea, vomiting), contribute to antibiotic resistance, increase healthcare costs, and risk laryngeal candidiasis 1, 2, 3
- Do NOT prescribe systemic corticosteroids routinely for viral laryngitis in adults due to lack of efficacy evidence and significant adverse effect profile (avascular necrosis, pancreatitis, diabetogenesis, candidiasis) 1, 2
- Do NOT prescribe proton pump inhibitors (PPIs) empirically for isolated dysphonia without laryngoscopy—multiple placebo-controlled trials show no benefit (RR 1.28,95% CI 0.94-1.74) 1, 4
Management of Chronic Laryngitis
When Laryngoscopy Shows Inflammatory Changes
If laryngoscopy reveals erythema, edema, or surface irregularities of the vocal folds, arytenoid mucosa, or posterior commissure:
- Consider laryngopharyngeal reflux (LPR) as a potential etiology, but only after visualization confirms inflammation 1
- Lifestyle modifications are the cornerstone: weight loss if BMI >25, head of bed elevation, avoiding meals within 2-3 hours of bedtime, left lateral sleeping position 4
- PPI therapy may be considered (esomeprazole 40 mg twice daily or equivalent) ONLY when combined with lifestyle modifications AND when laryngeal inflammation is documented 1, 4
- Important caveat: LPR symptoms may take up to 3 months to improve (versus 4-8 weeks for typical GERD symptoms), so reassess at 8-12 weeks 4
- If no improvement after 3 months of appropriate therapy, perform objective testing (esophageal manometry and pH-metry) rather than trying additional medications 4
Chronic Bacterial Laryngitis (Rare)
Consider bacterial laryngitis when:
- Symptoms persist beyond 3 weeks despite appropriate management 5, 6
- Patient is immunocompromised (55% of culture-positive cases) 5
- Already on acid suppression without improvement (90% of culture-positive cases) 5
Culture-directed approach:
- Obtain laryngeal cultures via direct laryngoscopy with biopsy if needed 5, 6
- Most common organisms: Klebsiella sp. (27.5%), Staphylococcus sp. (27.5%), MRSA (13.7%) 5
- Multiple bacterial species found in 41% of cases, with concomitant fungal isolates in 34.5% 5
- For MSSA/MRSA: Extended antibiotic courses (average 10 days, but often requiring multiple prolonged courses) may be necessary 5, 6
- For other organisms (Pseudomonas, Serratia): Single course typically sufficient 6
- Symptom improvement or resolution occurs in 72% after culture-directed therapy 5
Special Populations and Circumstances
Immunocompromised Patients
- Antibiotics may be appropriate for documented bacterial infection (e.g., laryngeal tuberculosis in transplant patients) 1
- Lower threshold for obtaining cultures given higher risk of atypical infections 5
Pediatric Laryngitis (Croup)
- Oral corticosteroids are strongly recommended for pediatric laryngitis 7
- Add adrenaline inhalations in severe cases with stridor or respiratory distress 7
Post-COVID-19 Dysphonia
- Dysphonia prevalence ranges from 0.39% to 79% in COVID-19 patients 8
- Common findings include unilateral vocal fold paralysis, inflammatory laryngitis, and muscle tension dysphonia 8
- All patients with persistent vocal symptoms post-COVID should undergo videolaryngoscopy and acoustic vocal analysis 8
- Omicron variant can cause severe transglottic swelling requiring emergency airway management—suspect if "muffled speech," dysphagia, severe odynophagia, or inspiratory stridor present 9
Critical Pitfalls to Avoid
- Do not prescribe antibiotics for colored sputum alone—this does not indicate bacterial infection 2
- Do not prescribe PPIs without laryngoscopy for isolated dysphonia—this leads to missed diagnoses, delayed appropriate treatment, and exposes patients to long-term PPI risks (hip fractures, vitamin B12 deficiency, chronic kidney disease, impaired cognition) 1, 4
- Do not continue empiric therapy beyond 3 months without response—proceed to objective testing instead 4
- Do not add H2-receptor antagonists to twice-daily PPIs—no evidence of improved efficacy and H2RAs develop tachyphylaxis 4
- Do not use steroids empirically without a specific diagnosis and shared decision-making about risks versus limited benefits 1